North Dakota biologics regulations.
Who may administer PRP, exosomes and stem cells in North Dakota, and which agencies to check.

Who may administer biologics in North Dakota?
In North Dakota, only licensed medical professionals, such as MDs, DOs, and advanced practice providers (RN/PA) under supervision, may perform stem cell therapies. Practitioners should meet all relevant credentialing requirements, which can be verified through the North Dakota Board of Medicine.
Official sources
North Dakota compliance guide.
FDA Compliance
The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps). Clinics must comply with FDA regulations for HCT/Ps to legally administer stem cell therapies. This includes adhering to Good Manufacturing Practices (GMP), proper labeling, and reporting adverse events. For an overview of federal guidelines, visit the FDA's website.
North Dakota State Regulations
North Dakota’s biologics regulations align closely with federal requirements, but there may be additional state-specific regulations. Clinics should consult the North Dakota Department of Health for current guidelines. Understanding these state standards is essential for accessible and achievable compliance, as they govern licensing, handling, and clinical protocols.
Provider Qualifications
In North Dakota, only licensed medical professionals, such as MDs, DOs, and advanced practice providers (RN/PA) under supervision, may perform stem cell therapies. Practitioners should meet all relevant credentialing requirements, which can be verified through the North Dakota Board of Medicine. Meeting these requirements enables providers to confidently deliver biologics within legal standards.
Patient Informed Consent
Before administering biologic treatments, North Dakota clinics must obtain informed consent from patients. This includes a clear explanation of the therapy’s experimental nature, potential risks and benefits, and any disclaimers about treatment outcomes. Informed consent ensures patients understand their choices and acknowledges the investigational status of certain therapies.
Additional Compliance Considerations
Pre-Treatment and Post-Treatment Protocols
Clinics should develop comprehensive pre-treatment and post-treatment protocols to ensure patient safety. These protocols might include patient eligibility criteria, medical history assessments, and follow-up procedures to monitor outcomes and adverse events.
Standard Operating Procedures (SOPs)
Implementing SOPs is crucial for maintaining compliance and consistency in biologic administration. SOPs should cover procedures for patient handling, injection processes, equipment sterilization, and emergency response.
Medical Liability Insurance
Medical liability insurance is recommended for all North Dakota providers offering biologics. Consult with a licensed insurance provider to understand the coverage options tailored to biologic therapies.
Marketing and Advertising Compliance
All marketing materials should comply with FDA and North Dakota advertising regulations. Avoid misleading claims and ensure that any information presented is accurate and supported by clinical evidence.
This guide is a general summary to help clinics understand compliance requirements for biologics in North Dakota. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
North Dakota: common questions.
Who can administer stem cells, PRP and exosomes in North Dakota?
Are stem cell and exosome therapies FDA-approved in North Dakota?
Do I need an IRB-approved study to offer biologics in North Dakota?
How do I start offering biologics in North Dakota?
Practising in North Dakota? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.